NCT00658151

Brief Summary

The hypothesis is that there are unique sonographic characteristics of antibiotic-associated diarrhea. We will compare the ultrasound findings in patients who received antibiotics and developed diarrhea to toxin analysis for clostridium difficile in stool in order to find differences in the sonographic findings in the positive and negative cases.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 8, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 14, 2008

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Last Updated

April 14, 2008

Status Verified

April 1, 2008

Enrollment Period

9 months

First QC Date

April 8, 2008

Last Update Submit

April 11, 2008

Conditions

Keywords

focusstudyevaluatesonographicfindingscolonpatientsdeveloped

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in internal and geriatrics departments who developed diarrhea in a period of 72 hours since the beginning of admission and received antibiotics.

You may qualify if:

  • admitted patients who developed diarrhea in 72 hours since the beginning of admission
  • patients age above 18 years.
  • patients received antibiotics during admission

You may not qualify if:

  • other reasons of diarrhea
  • drugs induced diarrhea
  • length of time since the beginning of diarrhea is shorter than 72 hours.
  • patients had diarrhea during the first day of admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaare Zedek Medical Center

Jerusalem, Israel

Location

Central Study Contacts

Michael Avital, doctor

CONTACT

Yonit Veiner, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 8, 2008

First Posted

April 14, 2008

Study Start

April 1, 2008

Primary Completion

January 1, 2009

Last Updated

April 14, 2008

Record last verified: 2008-04

Locations